Here are relevant reports on : pet-tech-market
-
Monoethylene Glycol (MEG) Market by Application (Fiber, PET, Antifreeze & Coolant, Film), Technology, and Geography (Asia Pacific, North America, Europe, Middle East & Africa, and South America) - Global Forecast to 2022
The MEG market is estimated at USD 24.41 Billion in 2017 and is projected to reach USD 30.40 Billion by 2022, at a CAGR of 4.5% from 2017 to 2022. The MEG market is expected to be driven by the increasing need for MEG in the production of PET and polyester. Polyester is mainly used in the textile end-use industry. PET application is growing in packaging end-use industry which is growing at a very high growth rate. Increasing dispensable income of the population across the world has propelled the growth of packaging end-use industry in turn fueling the growth in PET application in MEG market. The key players operating in the MEG market are SABIC (Saudi Arabia), Formosa (Taiwan), Dow (US), BASF SE (Germany), MEGlobal (UAE), Sinopec (China), Shell (Netherlands), Reliance (India), and SIBUR (Russia). These companies undertake dynamic business strategies that propel the growth of the MEG market.
- Published: January 2018
- Price: $ 4950
- TOC Available:
-
Commodity Plastics Market by Type (PE, PP, PVC, PS, ABS, PET, PMMA), End-use Industry (Packaging, Construction, Consumer Goods, Automotive, Electronics, Textiles, Medical & Pharmaceutical), and Region - Global Forecast to 2025
The commodity plastics market is expected to grow from USD 468.3 billion in 2020 to USD 596.1 billion by 2025, at a compound annual growth rate (CAGR) of 6.0% during the forecast period.Exxon Mobil (US), LG Chem (South Korea), Sumitomo Chemical (Japan), The Dow Chemical Company (US), SABIC (Saudi Arabia), BASF SE (Germany), LyondellBasell (Netherlands), Sinopec (China), Ineos (Switzerland), Formosa Plastics (Taiwan), Mitsubishi Chemical (Japan), Borealis AG (Austria), Chevron Phillips Chemical (US), ENI SpA (Italy), Reliance Industries (India), Braskem (Brazil), Hanwha Chemical (South Korea), Lotte Chemical (South Korea), Indian Oil (India), Haldia Petrochemicals (India), Nova Chemicals (Canada), Qenos Pty (Australia), Qatar Petroleum (Qatar), Westlake Chemical (US), and PTT Global Chemical (Thailand).
- Published: January 2021
- Price: $ 4950
- TOC Available:
-
Advanced Visualization Market by Type (Enterprise, Standalone), Modality (MRI, CT, PET, Ultrasound, Radiotherapy, Nuclear Medicine), Application (Radiology, Oncology, Neuro), End User (Hospital, ASC, Diagnostic Center) & Region - Global Forecast to 2029
The global advanced visualization market, valued at US$3.36 billion in 2023, stood at US$3.78 billion in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$6.55 billion by the end of the period. Technological advancements in advanced visualization tools, the rising need for early detection of diseases, and the growing support from government & private organizations are key factors driving the market growth.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Thyroid, Cardiology), Procedures - Forecasts to 2020
Over the years, the European nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The European radiopharmaceuticals market is witnessing growth owing to an increasing number of radioisotope approvals for different clinical indications. Tc-99m and F-18 radioisotopes are estimated to contribute the highest to the European nuclear medicine diagnostic market in 2015, whereas Ra-223, I-131 and Y-90 ensured their leading position in the therapeutic market. The European nuclear medicine/radiopharmaceuticals market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, growing at a CAGR of 8.2% from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017
The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium–201(Tl-201), gallium–67 (Ga-67), and iodine-123 (I-123). SPECT is majorly used in cardiology-related diagnosis; it is poised to grow at a CAGR of 10.2% from 2012 to 2017. The radiopharmaceuticals market in the Asia-Pacific region was valued at $500.8 million in 2012; it is poised to reach $824.9million in 2017 at a CAGR of 10.5%.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
Renewable Chemicals Market - Alcohols (Ethanol, Methanol), Biopolymers (Starch Blends, Regenerated Cellulose, PBS, Bio-PET, PLA, PHA, Bio-PE, and Others), Platform Chemicals & Others - Global Trends & Forecast to 2020
The global renewable chemicals market is estimated to be USD 49.0 billion in 2015 and is projected to reach USD 84.3 billion by 2020, at a CAGR of 11.47% between 2015 and 2020. The renewable chemicals market has been majorly segmented into alcohols, platform chemicals, and biopolymers. The alcohols accounts for more than 80.0% of the renewable chemicals market, in terms of value in 2015 and the same trend is projected to continue during the forecast period.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Engineering Plastics Market by Type (Acrylonitrile Butadiene Styrene (ABS), Polyamide, Polycarbonate, Thermoplastic Polyester (PET & PBT), Polyacetal, and Fluoropolymer), End-use Industry, and Region – Global Forecast to 2030
The engineering plastics market is expected to grow from USD 107.17 billion in 2025 to USD 130.98 billion by 2030, at a CAGR of 4.1% during the forecast period. The report profiles key companies, including BASF (Germany), Covestro AG (Germany), Celanese Corporation (US), DuPont (US), Syensqo (Belgium), LG Chem (South Korea), SABIC (Saudi Arabia), Evonik Industries AG (Germany), Mitsubishi Chemical Group Corporation (Japan), and Envalior (Germany).
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) & Region - Global Forecast to 2025
The global nuclear imaging equipment market growth is primed to transition from $2.6 billion in 2020 to $3.4 billion by 2025, showcasing a strong CAGR of 7.4%. The growth in this market is mainly driven by the the shift from standalone to hybrid modalities, advances in radiotracers, the increasing focus on personalized medicine, investments through public-private partnerships to modernize diagnostic imaging centers, and the increasing incidence and prevalence of cancer and cardiac ailments.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Ethylene Oxide and Ethylene Glycol Market by Product Type (Ethylene Glycol, Ethoxylates, Ethanolamines, Glycol Ethers), Application (Polyester Fibers, Antifreeze & Coolants, PET Resins), End-Use Industries, and Region - Global Forecast to 2029
The ethylene oxide and ethylene glycol market is expected to grow from USD 39.7 billion in 2024 to USD 51.9 billion by 2029, at a CAGR of 5.5% during the forecast period. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the ethylene oxide and ethylene glycol market. These are BASF SE (Germany), SABIC (Saudi Arabia), Shell Plc (UK), Dow Chemical Company (US), and ExxonMobil Corporation (US).
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Preclinical Imaging Market by Product (Optical Imaging (Bioluminescence), Nuclear Imaging (PET, SPECT), MRI, Reagents (Luciferins, Infrared Dyes), Software), Application (Onco, Cardio), End User (Pharma, Biotech, Academic, CRO) - Global Forecast to 2030
The global preclinical imaging market, valued at US$3.36 billion in 2024, stood at US$3.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.5% from 2024 to 2030, culminating in a forecasted valuation of US$4.39 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
